These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 31190658)
1. Sodium valproate in psychiatric practice: time for a change in perception. Owens DC Br J Psychiatry; 2019 Sep; 215(3):516-518. PubMed ID: 31190658 [TBL] [Abstract][Full Text] [Related]
2. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age. Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033 [TBL] [Abstract][Full Text] [Related]
3. [French Expert advice on the management of valproate in childbearing and pregnant women with bipolar disorder]. Samalin L; Arnould A; Boudieu L; Henry C; Haffen E; Drapier D; Anmella G; Pacchiarotti I; Vieta E; Belzeaux R; Llorca PM Encephale; 2022 Dec; 48(6):624-631. PubMed ID: 36257849 [TBL] [Abstract][Full Text] [Related]
4. Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk? Baldwin DS; Amaro HJF CNS Drugs; 2020 Feb; 34(2):163-169. PubMed ID: 31845215 [TBL] [Abstract][Full Text] [Related]
5. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit. Goldspink R; Pumipi T; Dey S; Menkes DB Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113 [TBL] [Abstract][Full Text] [Related]
6. Prescription of Sodium Valproate as a Mood Stabiliser in Pregnancy. Womersley K Psychiatr Danub; 2017 Sep; 29(Suppl 3):679-684. PubMed ID: 28953852 [TBL] [Abstract][Full Text] [Related]
7. Brief intervention reduces prescription of sodium valproate in women of childbearing age. Goldspink R; Pumipi T; Menkes DB Australas Psychiatry; 2023 Aug; 31(4):524-527. PubMed ID: 37035997 [TBL] [Abstract][Full Text] [Related]
8. Are female bipolar patients of reproductive age aware of the teratogenic risk of sodium valproate? A qualitative study. Sibanyoni AU; Joubert M; Naidu K S Afr J Psychiatr; 2022; 28():1719. PubMed ID: 35169512 [TBL] [Abstract][Full Text] [Related]
9. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171 [TBL] [Abstract][Full Text] [Related]
10. Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience-a European perspective. Toledo M; Mostacci B; Bosak M; Jedrzejzak J; Thomas RH; Salas-Puig J; Biraben A; Schmitz B J Neurol; 2021 Aug; 268(8):2735-2748. PubMed ID: 32239268 [TBL] [Abstract][Full Text] [Related]
11. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach? Macfarlane A; Greenhalgh T BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057 [TBL] [Abstract][Full Text] [Related]
12. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data]. Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910 [TBL] [Abstract][Full Text] [Related]
13. Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016. Charlton R; Damase-Michel C; Hurault-Delarue C; Gini R; Loane M; Pierini A; Puccini A; Neville A; Snowball J; Morris JK; Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1519-1528. PubMed ID: 31452307 [TBL] [Abstract][Full Text] [Related]
14. Patterns in Psychiatrists' Prescription of Valproate for Female Patients of Childbearing Age With Bipolar Disorder in Japan: A Questionnaire Survey. Tachibana M; Hashimoto T; Tanaka M; Watanabe H; Sato Y; Takeuchi T; Terao T; Kimura S; Koyama A; Ebisawa S; Shizu Y; Nagase T; Hirakawa J; Hatta K; Nakazato M; Iyo M Front Psychiatry; 2020; 11():250. PubMed ID: 32351410 [TBL] [Abstract][Full Text] [Related]
15. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness? Perera C; Patterson S; Bruxner G Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123 [TBL] [Abstract][Full Text] [Related]
16. Sodium valproate and the fetus: a case study and review of the literature. Smith J; Whitehall J Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633 [TBL] [Abstract][Full Text] [Related]
17. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS. Cerbo AD Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106 [TBL] [Abstract][Full Text] [Related]
18. Measures to Mitigate Sodium Valproate Use in Pregnant Women With Epilepsy. Ranjith S; Joshi A Cureus; 2022 Oct; 14(10):e30144. PubMed ID: 36381886 [TBL] [Abstract][Full Text] [Related]
19. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study. Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478 [TBL] [Abstract][Full Text] [Related]
20. A review of valproate in psychiatric practice. Haddad PM; Das A; Ashfaq M; Wieck A Expert Opin Drug Metab Toxicol; 2009 May; 5(5):539-51. PubMed ID: 19409030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]